Cited by

• Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.

  Harris M, Wang XG, Jiang Z, Phaeton R, Koba W, Goldberg GL, Casadevall A, Dadachova E. Harris M, et al. Br J Cancer. 2013 Mar 5;108(4):859-65. doi: 10.1038/bjc.2013.43. Epub 2013 Feb 5. Br J Cancer. 2013. PMID: 23385729 Free PMC article.
• Combination of flavone acetic acid (FAA) with adriamycin, cis-platinum and difluoromethylornithine (DFMO) in vitro against human colon cancer cells.

  Neelam SS, Bernabei A, Freedland C, Thompson R, Corbett TH, Luk GD. Neelam SS, et al. Invest New Drugs. 1990 Aug;8(3):263-8. doi: 10.1007/BF00171835. Invest New Drugs. 1990. PMID: 2272766
• Identification of semaphorin E as a non-MDR drug resistance gene of human cancers.

  Yamada T, Endo R, Gotoh M, Hirohashi S. Yamada T, et al. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14713-8. doi: 10.1073/pnas.94.26.14713. Proc Natl Acad Sci U S A. 1997. PMID: 9405678 Free PMC article.
• Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.

  Orr RM, O'Neill CF, Nicolson MC, Barnard CF, Murrer BA, Giandomenico CM, Vollano JF, Harrap KR. Orr RM, et al. Br J Cancer. 1994 Sep;70(3):415-20. doi: 10.1038/bjc.1994.320. Br J Cancer. 1994. PMID: 8080724 Free PMC article.
• Copper(II) and manganese(III) complexes of N'-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer.

  Shrivastav A, Singh NK, Tripathi P, George T, Dimmock JR, Sharma RK. Shrivastav A, et al. Biochimie. 2006 Sep;88(9):1209-16. doi: 10.1016/j.biochi.2006.03.004. Epub 2006 Mar 24. Biochimie. 2006. PMID: 16600465 Free PMC article.